ProPharma uses an innovative technology platform that leverages AI and automation to identify and redact or de-identify both PPI (Personally Protected Information) and CCI. Our experienced redaction specialists apply a methodical two-step approach to the redaction of each document, to ensure patient and company confidential information are appropriately identified.
Once all content has been identified for redaction, each document undergoes a rigorous quality review to ensure not only the protection of all relevant information but also the consistent application of all applicable standards and regulations (including both industry standards (e.g., TransCelerate) and client specific guidelines).
Our innovative redaction technology platform:
Provides data and document de-identification and anonymization
Can redact multiple documents at once
Allows for multiple input types (.xpt, .sas, .pdf, etc)
Determines risk for re-identification and data utility
Auto-generates anonymization reports
Allows for re-use by applying the appropriate formatting based on intended audience without the need to re-redact/re-review